FLD
Fold Holdings, Inc. Class A Common StockNASDAQFINANCIAL SERVICESCAPITAL MARKETS
Key Statistics
Market Cap
$34.02M
P/E Ratio
—
EPS
$-0.32
Beta
0.26
52W High
$4.88
52W Low
$0.56
50-Day MA
$1.21
200-Day MA
$2.33
Dividend Yield
—
Profit Margin
-164.60%
Forward P/E
—
PEG Ratio
—
About Fold Holdings, Inc. Class A Common Stock
Fold Holdings, Inc. (FLD) is an innovative biotechnology company dedicated to advancing therapies for severe genetic and rare diseases through its pioneering research initiatives. With a robust product pipeline fortified by proprietary technologies and strategic collaborations, Fold is well-positioned to capitalize on emerging market opportunities. Its commitment to scientific excellence and patient-focused solutions underscores its potential for sustainable growth and value creation, making FLD an attractive investment prospect in the rapidly evolving healthcare sector.
Fundamentals
| Revenue (TTM) | $30.30M |
| Gross Profit (TTM) | $-13.26M |
| EBITDA | $-26.89M |
| Operating Margin | -167.00% |
| Return on Equity | -92.20% |
| Return on Assets | -15.00% |
| Revenue/Share (TTM) | $0.63 |
| Book Value | $0.72 |
| Price-to-Book | 0.94 |
| Price-to-Sales (TTM) | 1.12 |
| EV/Revenue | 1.804 |
| EV/EBITDA | 4.04 |
| Quarterly Earnings Growth (YoY) | 1622.00% |
| Quarterly Revenue Growth (YoY) | -21.10% |
| Shares Outstanding | $50.78M |
| Float | $6.40M |
| % Insiders | 72.39% |
| % Institutions | 18.67% |
Historical Volatility
HV 10-Day
146.68%
HV 20-Day
119.06%
HV 30-Day
118.50%
HV 60-Day
135.08%
HV Rank
73.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($3.41 target)
3
BuyMore FINANCIAL SERVICES Stocks
Data last updated: 6/13/2026